1-12 of 12
Mohamed El-Hamri
Close
Sort by
Journal Articles

Acute Myeloid Leukemia and Antifungal Prophylaxis Era: Compliance of AML Centers, Invasive Fungal Infection (IFI) Classification, IFI Incidence and AML Outcomes from ALFA 2007- 02 Study

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Stephane Morisset, BioStat, Alexandre Deloire, CRA, Emmanuel Raffoux, MD, Stephane De Botton, Denis Caillot, MD, Sylvain Chantepie, MD, Stephane Girault, MD, Celine Berthon, MD, Sarah Bertoli, MD PhD, Stephane Lepretre, Thibaut Leguay, MD, Sylvie Castaigne, MD, Jean-Pierre Marolleau, MD PhD, Cecile Pautas, MD, Jean Valère Malfuson, MD, Norbert Vey, MD PhD, Lauris Gastaud, Felipe Suarez, MD PhD, Aline Schmidt, MD, Rémy Gressin, MD, Caroline Bonmati, MD, Karine Celli-Lebras, CRA, Mohamed El-Hamri, CRA, Patricia Ribaud, MD, Herve Dombret, MD PhD, Xavier Thomas, MD PhD, Anne Bergeron
Journal: Blood
Blood (2019) 134 (Supplement_1): 2618.
https://doi.org/10.1182/blood-2019-130642
Published: 2019
Journal Articles

Outcome of Patients Receiving Extracorporeal Photopheresis for Steroid Resistant Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Alexandre Deloire, CRA, Daniela Revesz, MD, Youcef Chelgoum, MD, Mohamed El-Hamri, CRA, Franck-Emmanuel Nicolini, MD PhD, Hélène Labussière, MD, Olivier Hequet, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5720.
https://doi.org/10.1182/blood-2018-99-118206
Published: 2018
Journal Articles

Long-Term Outcome of Patients Receiving Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Results from an Observational Study on 106 Patients

Mauricette Michallet, MD PhD, Mohamad Sobh, Alexandre Deloire, CRA, Daniela Revesz, MD, Youcef Chelgoum, MD, Mohamed El-Hamri, CRA, Fiorenza Barraco, MD, Helene Labussiere-Wallet, MD, Franck Emmanuel Nicolini, MD PhD, Olivier Hequet, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4504.
https://doi.org/10.1182/blood.V130.Suppl_1.4504.4504
Published: 2017
Journal Articles

Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy. Prospective Observational Study from the Acute Leukemia French Association (ALFA) Group

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Alexandre Deloire, CRA, Emmanuel Raffoux, MD, Stephane de Botton, Denis Caillot, Oumedaly Reman, MD, Stephane Girault, MD, Celine Berthon, MD PhD, Francoise Huguet, MD, Stephane Lepretre, Thibaut Leguay, MD, Sylvie Castaigne, MD PhD, Bruno Royer, MD, Cecile Pautas, MD, Jean-Valere Malfuson, MD, Jose Fernandes, MD, Thomas Prebet, MD, Thorsten Braun, MD, Lauris Gastaud, MD, Felipe Suarez, MD PhD, Aline Schmidt, MD, Remy Gressin, MD, Jacques Delaunay, MD, Caroline Bonmati, MD, Karine Celli-Lebras, CRA, Mohamed El-Hamri, CRA, Herve Dombret, MD PhD, Xavier Thomas, MD PhD, Anne Bergeron, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3696.
https://doi.org/10.1182/blood.V128.22.3696.3696
Published: 2016
Journal Articles

TET2 Exon 2 Skipping Confers Sensitivity to AraC and Is an Independent Favorable Prognostic Factor in AML Patients Treated with Intensive Chemotherapy

Aminetou Mint Mohamed, Marie Balsat, Lea Payen-Gay, Delphine Maucort-Boulch, MD PhD, Meyling Cheok, BSPharm, PhD, Hussein Mortada, Didier Auboeuf, Mohamed El-Hamri, Catherine Koering, Isabelle Tigaud, MD, Charles Dumontet, MD PhD, Emeline Cros, AE, Pascale Flandrin-Gresta, Olivier Nibourel, Claude Preudhomme, Xavier Thomas, MD PhD, Franck E. Nicolini, MD PhD, Francoise Solly, MD, Denis Guyotat, MD, Lydia Campos, MD PhD, Franck Mortreux, Eric Wattel
Journal: Blood
Blood (2014) 124 (21): 68.
https://doi.org/10.1182/blood.V124.21.68.68
Published: 2014
Journal Articles

Skipping of ATP-Binding Cassette Transporter A3 Exon 19 in AML Cells Is an Independent Prognostic Factor in Patients with Normal Cytogenetics

Aminetou Mint Mohamed, Morgan Thenoz, Lea Payen-Gay, Delphine Maucort-Boulch, MD PhD, Hussein Mortada, Didier Auboeuf, Catherine Koering, Meyling Cheok, Olivier Nibourel, Claude Preudhomme, Mohamed El-Hamri, Xavier Thomas, MD PhD, Franck E. Nicolini, MD PhD, Isabelle Tigaud, MD, Emeline Cros, AE, Charles Dumontet, MD PhD, Lydia Campos, MD PhD, Francoise Solly, MD, Denis Guyotat, MD, Pascale Flandrin-Gresta, Franck Mortreux, Eric Wattel
Journal: Blood
Blood (2014) 124 (21): 2324.
https://doi.org/10.1182/blood.V124.21.2324.2324
Published: 2014
Journal Articles

L-Asparaginase Sensitivity and Asparagine Synthetase Expression In Primary Tumor Cells From AML Patients

Willy Berlier, PhD, Karine Aguera, Mohamed El Hamri, PhD, Marie-Pierre Goutagny, Fanny Gallix, Yves Bertrand, MD, Xavier Thomas, MD, Yann Godfrin, PhD
Journal: Blood
Blood (2013) 122 (21): 1423.
https://doi.org/10.1182/blood.V122.21.1423.1423
Published: 2013
Journal Articles

Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation For High Risk Acute Myeloid Leukemia Patients In First Complete Remission: A Prospective Pilot Study

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Marie Y. Detrait, MD, Helene Labussiere, MD, Sandrine Hayette, PhD, Isabelle Tigaud, MD, Mohamed El Hamri, PhD, Lila Gilis, MD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Valentina Bozzoli, MD, Franck E. Nicolini, MD, PhD, Xavier Thomas, MD
Journal: Blood
Blood (2013) 122 (21): 2162.
https://doi.org/10.1182/blood.V122.21.2162.2162
Published: 2013
Journal Articles

Blast Asparagine Synthetase Deficiency in Acute Myeloid Leukemia

Willy Berlier, PhD, Mohamed El Hamri, PhD, Karine Aguera, Yannick Campion, Fabien Gay, PhD, Yann Godfrin, PhD, Xavier Thomas, MD
Journal: Blood
Blood (2012) 120 (21): 4333.
https://doi.org/10.1182/blood.V120.21.4333.4333
Published: 2012
Journal Articles

Invasive Aspergillosis: A New Important Risk Factor On Short and Long-Term Survival of AML Patients.

Mauricette Michallet, MD, PhD, Thomas Bénet, Samira Kraghel, Mohamad Sobh, Pharm.M, Mohamed El Hamri, PhD, Giovanna Cannas, MD, Franck Emmanuel Nicolini, MD, PhD, Emmanuelle Nicolas-Virelizier, MD, Hélène Labussière, MD, Sophie Ducastelle, MD, Roberto Crocchiolo, MD, Fiorenza Barraco, MD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Marie-Christine Nicoll, Anne-Lise Bienvenu, Florence Persat, Frédérique De Monbrison, Najeeb Fanari, MD, Samia Madene, MD, Philippe Vanhems, MD
Journal: Blood
Blood (2009) 114 (22): 1010.
https://doi.org/10.1182/blood.V114.22.1010.1010
Published: 2009
Journal Articles

Allogeneic Hematopoietic Stem Transplantation Does Not Erase the Impact of the New Prognosis Classification in AML and the Negative Influence of Evi1 and Flt3 ITD Mutations.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Sandrine Hayette, MD, Carole Charlot, Mohamed El Hamri, PhD, Nathalie Tedone, Franck Emmanuel Nicolini, MD, PhD, Giovanna Cannas, MD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Virelzier, MD, Sophie Ducastelle, MD, Fiorenza Baracco, MD, Isabelle Tigaud, MD, Xavier Thomas, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4678.
https://doi.org/10.1182/blood.V114.22.4678.4678
Published: 2009
Journal Articles

Validation of Positive Effect of Posaconazole Prophylaxis During Induction Chemotherapy in AML: Study of Invasive Aspergillosis Incidence and of Risk Factors On Short and Long-Term Survival.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Stéphane Morisset, MSc, Giovanna Cannas, MD, Franck Emmanuel Nicolini, MD, PhD, Sophie Ducastelle, MD, Emmanuelle Nicolas-Virelizier, MD, Fiorenza Barraco, MD, Youcef Chelghoum, MD, Samira Kraghel, Nathalie Tedone, Mohamed El Hamri, PhD, Hélène Labussière, MD, Xavier Thomas, MD, PhD, Anne-Lise Bienvenu, Frédérique De Monbrison, Stéphane Picot, Marie-Christine Nicoll, Philippe Vanhems, MD
Journal: Blood
Blood (2009) 114 (22): 4124.
https://doi.org/10.1182/blood.V114.22.4124.4124
Published: 2009